Phase I Study of Sunitinib With FOLFIRI (Irinotecan, 5-Fluorouracil and Leucovorin) for Advanced Gastroesophageal Cancers
Phase of Trial: Phase I
Latest Information Update: 23 Jun 2016
At a glance
- Drugs Sunitinib (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 20 Jun 2016 Status changed from active, no longer recruiting to discontinued as PI left institute.
- 01 Mar 2016 Planned End Date changed from 1 Feb 2016 to 1 May 2016 as reported by Clinical Trials.gov.